EcoDrugPlus

Ensembl ID : ENSACLG00000024938
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSACLG00000025156
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSACLG00000026248
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSACLG00000027524
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSACLG00000014067
Gene Symbol: -
1 Cross references
223 Possible Orthologues:

Ensembl ID : ENSACLG00000027522
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSACLG00000025460
Gene Symbol: -
Cross references: -
543 Possible Orthologues:

Ensembl ID : ENSACLG00000024900
Gene Symbol: -
1 Cross references
240 Possible Orthologues:

Ensembl ID : ENSACLG00000024870
Gene Symbol: -
1 Cross references
240 Possible Orthologues:

Ensembl ID : ENSACLG00000021207
Gene Symbol: S1PR1
1 Cross references
193 Possible Orthologues:

Ensembl ID : ENSACLG00000006758
Gene Symbol: RPS7
1 Cross references
370 Possible Orthologues:

Ensembl ID : ENSACLG00000023504
Gene Symbol: -
1 Cross references
273 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).